Optibiotix Health Share Discussion Threads

[parob] 27/6/2018 07:32

The SweetBiotix division is going to get increasingly busy over the next few months. I don't think it will be long now until someone is appointed to head up the division.

[aspex] 27/6/2018 05:13

elrico, To put not a too fine line on it the 20x PE is conservative during a true growth phase. One company I have that held back at 15 to 20 for a long period then had a couple of even better years and its PE is now over 50. At a similar point, I get quite nervous and have sold out of half but the price has added another 10 percent since. That same company has sent a couple of competitors off who had attempted patent violations and failed and Opti have hopefully made their IP as tight as possible.

[pglancy] 27/6/2018 00:54

You're not very bright are you monkey. You accuse everyone of ramping and now even Soh. Sums you up really.

[monkeywench1] 26/6/2018 22:14

Christ elrampo certainly knows how to ramp. I would be delighted if we got to half his estimate next year. Time will tell.

[paulhoodwinked] 26/6/2018 21:42

Bob, i think you have already convince most you are wooden top, no need to try so hard on the Opti thread. Too many smarts here for you.

[parob] 26/6/2018 20:39

From development to market, Cargill can help you reach your sugar reduction goals:hTtps://youtu.be/xeymucqqhY4SweetBiotix seems to fit in perfectly.

[dire cons] 26/6/2018 19:50

Knowing SOH's tight grip on cash, maybe we're paying for the 'no frills' options on p.r. and brokerage?
Edit. It's about time they got their collective fingers out regards the UK online sales.

[judijudi] 26/6/2018 19:41

imnotlong
I agree to a certain extent about PR
And Fincapp need to step up a gear
imho

[f3rdinand] 26/6/2018 19:38

If the profits for each deal are as SOH suggests they could be (and he's in a far better position to do so than yourself) I.e. low to mid six figure deals then hundreds of deals would imply profit of in excess of £25 million and most probably heading towards £50 million. Apply a sensible PE of 15 then a market cap of £750 million is likely or about £10 per share!That's not including a deal worth far more from the likes of Tata or a pharmaceutical (which imo could be in the millions in itself)Interesting POV though!

[bobalot] 26/6/2018 18:58

If another firm is making the stuff then revenue dewindles after all that groundbreaking R&D.

[nobbygnome] 26/6/2018 18:55

But quite often the key ingredient for marketing purposes....

[bobalot] 26/6/2018 18:53

Get real folks, OPTI is an ingredients inventor and maker. When a business does a deal the ingredient will be one amongst many, therefore hundreds of deals will have be made before the business makes many millions/ year on the back of patent payments and sub-contracted production.

The business has no owned manufacturing compound facilities with which to scale up, all subcontracted work will be draining cash in flow imo.

But the science is fantastic as a University project to be bought out; and that is what this amounts to imo.

[elrico] 26/6/2018 18:52

John - I'm pleased you're thankful for small mercy's.

The beauty of SlimBiome and SweetBiotix platform, is the fact they can be combined to promote weightless and reduce sugars. Imagine the price tag if this were to be come a reality via a household name partner.

[2350220] 26/6/2018 18:30

Elrico,
That was The shortest answer on record 😀.
Glad that that's the case and thanks for the reply,
John

[trotterstrading] 26/6/2018 18:08

Lol, makes a mockery of the current share price . something's got to change.. and it will

[parob] 26/6/2018 17:58

A recap of revenue streams to OPTI, with income being received already or should be in the near future:- GoFigure- Sacco- HLH BioPharma Vertriebs GmbH - Nutrilinia- Pharmabiota- Galenicum Special Ingredients - Knighton Foods- Cereal Ingredients Inc.- Fine Foods & Pharmaceuticals- Trigen Pharma- Cambridge Commodities - Akums Drugs and Pharma- Seed Health- Morley's - Alfasigma- Unnamed global corporate ($100B+ turnover) for SweetBiotix manufacturing.Following not confirmed by RNS yet:- Tata X 2 (Slimbiome and LPGOS)- Mystery US Slimbiome customer

[nobbygnome] 26/6/2018 17:55

Just a thought. It could be the placees in the fund raising holding the price back. I still have all of mine but my fellow investors may be looking a little more short term than me! I am in for the ride...

[trotterstrading] 26/6/2018 17:41

It will move up soon, prob on a non news day when you least expect it. All the pieces are falling into place, just a matter of time now

[f3rdinand] 26/6/2018 17:19

I've got a feeling some serious money will arrive when this moves away from the downtrend... however wtf is going to make it move!? Incessant number of deals; some with major companies but volume is still abysmal!

[parob] 26/6/2018 17:04

FinnCap today: A six-month exclusivity period to negotiate a licence agreement to scale up, manufacture and distribute SweetBiotix® with an unnamed global corporate, for which it will receive a six-figure sum, is a meaningful statement of intent. Whilst there is no certainty that the negotiations will lead to a full licence, this agreement could be very substantial given the scale of the corporate with which it has had initial discussions. This agreement sustains the accelerating trend of agreements with larger companies and represents the eighth agreement in 2018 across its product range; SlimBiome®, LP-LDL® and SweetBiotix®.

[elrico] 26/6/2018 16:52

John - No, is the short answer.

[imnotlong] 26/6/2018 16:52

Somebody sounds cross

[imnotlong] 26/6/2018 16:22

Opti PR machine not done much on the back of such a potentially significant announcement.